Page last updated: 2024-11-03

probucol and Obesity

probucol has been researched along with Obesity in 4 studies

Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
"We investigated the effect of Probucol in preventing fatty liver in monosodium-L-glutamate (MSG) treated obese mice and control mice fed a high fat diet."7.69Probucol prevents the progression of fatty liver in MSG obese mice. ( Kondo, M; Sakane, N; Umekawa, T; Yoshida, T; Yoshioka, K, 1995)
"We investigated the effect of Probucol in preventing fatty liver in monosodium-L-glutamate (MSG) treated obese mice and control mice fed a high fat diet."3.69Probucol prevents the progression of fatty liver in MSG obese mice. ( Kondo, M; Sakane, N; Umekawa, T; Yoshida, T; Yoshioka, K, 1995)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delaigle, AM1
Senou, M1
Guiot, Y1
Many, MC1
Brichard, SM1
Yoshida, T1
Yoshioka, K1
Sakane, N1
Umekawa, T1
Kondo, M1
Anikin, VV1
Savin, VV1
Lupanov, VP1
Razygraev, RA1
Miettinen, TA1
Huttunen, JK1
Naukkarinen, V1
Strandberg, T1
Vanhanen, H1

Trials

2 trials available for probucol and Obesity

ArticleYear
[Effect of probucol on cardiac electrophysiology in anginal patients with hyperlipidemia and diabetes mellitus type II].
    Terapevticheskii arkhiv, 2000, Volume: 72, Issue:8

    Topics: Aged; Angina Pectoris; Anticholesteremic Agents; Biomarkers; Blood Glucose; Body Mass Index; Cardiac

2000
Long-term use of probucol in the multifactorial primary prevention of vascular disease.
    The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Cerebrovascular Disorders; Cholesterol, HDL; C

1986

Other Studies

2 other studies available for probucol and Obesity

ArticleYear
Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies.
    Diabetologia, 2006, Volume: 49, Issue:6

    Topics: Adiponectin; Animals; Antioxidants; Body Weight; Cells, Cultured; Diabetes Mellitus, Type 2; DNA Pri

2006
Probucol prevents the progression of fatty liver in MSG obese mice.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1995, Volume: 103, Issue:2

    Topics: Animals; Anticholesteremic Agents; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholinesterases; Di

1995